Innovations Header bar

Editorial Feature:

Innovation Journal Club

Innovations in Cornea: Managing Low Astigmatism

Show Description +

As patients increasingly think about cataract surgery as a refractive procedure, the need to fine-tune the outcomes becomes increasingly important. In this episode, Gary Wörtz, MD, joins I. Paul Singh, MD, to discuss one area where surgeons can help patients achieve the best quality vision possible: management of astigmatism below 1.0 D.

Posted: 3/01/2024

Up Next

Innovations in Point of Service: Office-Based Surgery

I. Paul Singh, MD; and Daniel S. Durrie, MD


Innovations in Premium IOLs: Small-Aperture Lenses

I. Paul Singh, MD; and Karl G. Stonecipher, MD

Innovations in Dry Eye: The Expanding Toolkit

I. Paul Singh, MD; and John A. Hovanesian, MD, FACS

Innovations in Ocular Surface Disease: What is the Impact of Lifestyle?

I. Paul Singh, MD; and Christopher E. Starr, MD

Innovations in Cornea: What are FGFs?

I. Paul Singh, MD; and Nandini Venkateswaran, MD

Innovations in MIGS for the Anterior Segment Surgeon

I. Paul Singh, MD; and Blake K. Williamson, MD, MPH, MS

Innovations in Geographic Atrophy

I. Paul Singh, MD; and Charles C. Wykoff, MD, PhD, FACS

Innovations in …Mydriasis?

I. Paul Singh, MD; and Marguerite McDonald, MD, FACS

Innovations in AI: Applications in Ophthalmology

I. Paul Singh, MD; and Ranya Habash, MD

Innovations in Cataract Surgery: Let's Talk Technique!

I. Paul Singh, MD; and J. Morgan Micheletti, MD

Innovations in Astigmatism Management: Torics, LRIs, and Combinations

I. Paul Singh, MD; and Cathleen M. McCabe, MD

Innovations in Blepharitis: Prevalence and New Treatment Options

I. Paul Singh, MD; and Laura M. Periman, MD

Innovations in MIGS: A Look at the Pipeline

I. Paul Singh, MD; and Leonard K. Seibold, MD

Getting Patients to Open Up

I. Paul Singh, MD; and Darrell E. White, MD

Innovations in Vitreous Floaters: Laser Vitreolysis

I. Paul Singh, MD; and Darrell E. White, MD

Innovations in Innovation: How to Get Involved in Research

I. Paul Singh, MD; and Sila Bal, MD, MPH

Innovations in Ergonomics: Heads-Up Surgery

I. Paul Singh, MD; and Arjan Hura, MD

Getting Involved in Research

I. Paul Singh, MD; and Dagny Zhu, MD

Innovations in IOLs: EDOF, IC-8, and LAL

I. Paul Singh, MD; and William F. Wiley, MD

Innovations in Retina: PDS for AMD and ART for Complex MH

I. Paul Singh, MD; and Steve Charles, MD, FACS, FICS

Innovations in Glaucoma: State of the Science in Canaloplasty

I. Paul Singh, MD; and Mark J. Gallardo, MD

Innovations in Presbyopia: An Expanding Category

I. Paul Singh, MD; and Ralph Chu, MD

Canaloplasty: Benefits of Treating the Anatomy

I. Paul Singh, MD; and Mark J. Gallardo, MD

Innovations in Cataract Surgery: Going Dropless

I. Paul Singh, MD; and Cathleen M. McCabe, MD

Innovations in MIGS: Evolutions in Canaloplasty

I. Paul Singh, MD; and Damien F. Goldberg, MD

Innovations in Ophthalmic Practice: Work-Life Balance

I. Paul Singh, MD; and Darrell E. White, MD

Innovations in Glaucoma: Procedural Pharmaceuticals

I. Paul Singh, MD; and Steven R. Sarkisian Jr, MD

Treatment Burden in AMD: Implications for Patients and Providers

I. Paul Singh, MD; and Carl D. Regillo, MD

Innovations in AMD Therapy: Second-Generation Anti-VEGFs

I. Paul Singh, MD; and Carl D. Regillo, MD

Innovations in IOLs: Advancements in Monofocal Lens Technology

I. Paul Singh, MD; and Julie Schallhorn, MD

Innovations in MIGS: The Impact of Reimbursement Changes

I. Paul Singh, MD; and Sahar Bedrood, MD, PhD

Innovations in Medical Glaucoma: Preservative-Free Latanoprost

I. Paul Singh, MD; and Jason Bacharach, MD

Innovations in MIGS: The FLIGHT Procedure

I. Paul Singh, MD; and Robert J. Noecker, MD, MBA

Innovations in Presbyopia Management: Laser Scleral Microporation

I. Paul Singh, MD; and Mitchell A. Jackson, MD

Innovations in Retina: Gene Therapy

I. Paul Singh, MD; and David Eichenbaum, MD

Innovations in Glaucoma: Real-World Evidence

I. Paul Singh, MD; and Joe Panarelli, MD

Innovations in Cornea: Managing Low Astigmatism

As patients increasingly think about cataract surgery as a refractive procedure, the need to fine-tune the outcomes becomes increasingly important. In this episode, Gary Wörtz, MD, joins I. Paul Singh, MD, to discuss one area where surgeons can help patients achieve the best quality vision possible: management of astigmatism below 1.0 D.

Posted: 3/01/2024


Please log in to leave a comment.

Comments

lawrence tenkman

1 year ago

There's another very easy way to treat low corneal cyl: EXTRA KERATOME INCISIONS! McKool and I both independently developed on-axis keratome incisions at case end to reliably treat cyl. Single keratome incisions treat 0.2 if starting near limbus and 0.3 or so if started just a touch centrally (0.5 mL). Paired incisions 180 degrees apart treat 0.4 and 0.6 or even 0.7 depending how far in you start. Don't put extra incisions in until the end so they don't leak during the case. Because no instruments go through them, they almost never leak. But always check and hydrate PRN. If ergonomics prohibit you from operating on steep axis, you can use a separate surgical incision that is astigmatically neutral (by starting in limbal sclera, and knick the conj there to prevent exiting fluid from causing chemosis). I agree, Toric IOLs are far more accurate than incisions. So my plan is: 1. MILD cyl (0.7 and under): single or paired keratome incisions. 2. MODERATE TO HIGH cyl (0.8 to 4.6) - Toric IOL with subtractive (90 degrees away) or additive (on axis) keratome incisions. 3. SEVERE cyl (near 5.0 or greater) - Add an LRI instead of just extra keratomes to a full power toric IOL. So in this plan, LRIs (and their risk of neurotrophic keratitis or tissue instability) are only used in the most severe astigmatism cases. Just a few a year. Always base the treatment on a nomogram that assumes some posterior corneal astigmatism (Barrett). Don't just treat off of topography. I usually use the Alcon Toric Calculator, even if I know the cyl is too low for a toric IOL. I plan my keratomes off that. Our businesses do better when patients select upgrades, and it seems laser programs earn more upgrades. I think this is because of two things. One is promise of vision. Many surgeons link their astigmatism treatment & promise glasses freedom to the laser. Two is safety. Many of the videos that advertise laser cataract suggest that a surgeon doing the rhexis by hand is scary (and show an image of a shaky rhexis line then a dissheveled tilted IOL in the bag). If you count the "fear", I think it doubles the number of upgrades. In reality, I've found the manual rhexis to be far safer because it is stronger (not a micro-canopener saw tooth pattern). A surgeon doesn't have treat it with kid gloves or worry about radial extension of the rhexis from hydrodissection... the manual rhexis is strong and will almost never have such extension. So, there really are great ways to treat low astigmatism without LRIs (laser or manual). As time goes on, I think upgrades are becoming more and more about the IOL anyway.

Supported by

Tarsus Logo EF Zeiss Logo